Mark Thomas2023-03-22T08:43:40+09:30PRESS RELEASE: Carina to present at AACR 2023Mark Thomas2023-03-22T08:43:40+09:30March 22nd, 2023|
Kathy Sharrard2023-03-07T09:53:23+09:30PRESS RELEASE: Carina Biotech to Present Preclinical Data at Lorne Cancer 2023 Supporting Effectiveness of LGR5-Targeted CAR-T Cell Therapy Platform in Ovarian Cancer Tumor ModelsKathy Sharrard2023-03-07T09:53:23+09:30February 7th, 2023|
Kathy Sharrard2023-03-22T09:18:42+09:30Carina receives ‘Safe to proceed’ letter for Phase 1/2a clinical trial of CNA3103Kathy Sharrard2023-03-22T09:18:42+09:30January 24th, 2023|
Kathy Sharrard2023-03-08T11:03:45+09:30Carina Biotech submits an Investigational New Drug (IND) application to the US FDA for LGR5-Targeted CAR-T Cell Therapy CandidateKathy Sharrard2023-03-08T11:03:45+09:30December 15th, 2022|
